Filing Details
- Accession Number:
- 0001567619-19-008166
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-02 16:35:03
- Reporting Period:
- 2019-03-29
- Accepted Time:
- 2019-04-02 16:35:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1668397 | Medpace Holdings Inc. | MEDP | Services-Commercial Physical & Biological Research (8731) | 320434904 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1677297 | P Stephen Ewald | C/O Medpace Holdings, Inc. 5375 Medpace Way Cincinnati OH 45227 | General Counsel & Corp. Secy. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-03-29 | 7,946 | $57.95 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2018.
- The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $57.51 to $58.80. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.